CD147 reinforces [Ca2+]i oscillations and promotes oncogenic progression in hepatocellular carcinoma.


Oscillations in intracellular Ca2+ concentrations ([Ca2+]i) mediate various cellular function. Although it is known that [Ca2+]i oscillations are susceptible to dysregulation in tumors, the tumor-specific regulators of [Ca2+]i oscillations are poorly characterized. We discovered that CD147 promotes hepatocellular carcinoma (HCC) metastasis and proliferation by enhancing the amplitude and frequency of [Ca2+]i oscillations in HCC cells. CD147 activates two distinct signaling pathways to regulate [Ca2+]i oscillations. By activating FAK-Src-IP3R1 signaling pathway, CD147 promotes Ca2+ release from endoplasmic reticulum (ER) and enhances the amplitude of [Ca2+]i oscillations. Furthermore, CD147 accelerates ER Ca2+refilling and enhances the frequency of [Ca2+]i oscillations through activating CaMKP-PAK1-PP2A-PLB-SERCA signaling pathway. Besides, CD147-promoted ER Ca2+ release and refilling are tightly regulated by changing [Ca2+]i. CD147 may activate IP3R1 channel under low [Ca2+]i conditions and CD147 may activate SERCA pump under high [Ca2+]i conditions. CD147 deletion suppresses HCC tumorigenesis and increases the survival rate of liver-specific CD147 knockout mice by regulating [Ca2+]i oscillations in vivo. Together, these results reveal that CD147 functions as a critical regulator of ER-dependent [Ca2+]i oscillations to promote oncogenic progression in HCC.

DOI: 10.18632/oncotarget.5225

Cite this paper

@article{Tang2015CD147R, title={CD147 reinforces [Ca2+]i oscillations and promotes oncogenic progression in hepatocellular carcinoma.}, author={Juan Tang and Yun-shan Guo and Xiaoling Yu and Wan Huang and Ming Zheng and Ying-Hui Zhou and Gang Nan and Jianchao Wang and Hai-Jiao Yang and Jing-Min Yu and Jian-li Jiang and Zhi Chen}, journal={Oncotarget}, year={2015}, volume={6 33}, pages={34831-45} }